Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Plasma levels of LL37 in patients with and at risk of acute lung injury

Rachel Dancer, Gavin Perkins, Daniel Park, David Thickett
European Respiratory Journal 2011 38: p804; DOI:
Rachel Dancer
1Department of Respiratory Science, University of Birmingham, Birmingham, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gavin Perkins
2Clinical Trials Unit, University of Warwick, Coventry, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Park
1Department of Respiratory Science, University of Birmingham, Birmingham, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Thickett
1Department of Respiratory Science, University of Birmingham, Birmingham, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Cathelicidins are a group of antimicrobial peptides with a wide range of functions including immunomodulation, chemoattraction, angiogenesis and antimicrobial effects. LL-37 is the active form of the only known human example of a cathelicidin, HCAP-18. It is induced by the local action of 1,25-OH vitamin D. LL37 is expressed by many different cells including lung epithelial cells, neutrophils and other immune cells. We have shown that patients with severe vitamin D deficiency have an increased risk of Acute Lung Injury post-oesophagectomy and hypothesized that this may be related to the effects of vitamin D on LL37.

Methods: Plasma levels of LL37 were determined by ELISA in a cohort of patients with Acute Lung Injury and in a cohort of patients at risk of Acute Lung Injury due to undergo oesophagectomy.

Results: Average pre-operative plasma LL37 levels in the oesophagectomy cohort were 117.2ng/ml and post operative levels are significantly lower (p=0.027, paired t test). In our ALI cohort, median levels of LL37 on day 0 lower than normal levels (p=0.017). LL37 levels correlate with vitamin D status, however, preoperative LL37 levels did not predict Acute Lung Injury.

Conclusion: LL37 levels are lower than normal in patients with Acute Lung Injury and fall perioperatively in patients undergoing oesophagectomy. The mechanism underlying this is unclear and requires further evaluation, but may be related to vitamin D deficiency in these patients.

  • © 2011 ERS
Previous
Back to top
Vol 38 Issue Suppl 55 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Plasma levels of LL37 in patients with and at risk of acute lung injury
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Plasma levels of LL37 in patients with and at risk of acute lung injury
Rachel Dancer, Gavin Perkins, Daniel Park, David Thickett
European Respiratory Journal Sep 2011, 38 (Suppl 55) p804;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Plasma levels of LL37 in patients with and at risk of acute lung injury
Rachel Dancer, Gavin Perkins, Daniel Park, David Thickett
European Respiratory Journal Sep 2011, 38 (Suppl 55) p804;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Intravenous immunoglobulin in community acquired pneumonia
  • PTX3 as a component of innate immunity in the role of captopril in acute lung injury induced by bacterial endotoxin
  • Temporal characterization of murine genomic response to poly I:C stimulation reveals tri-phasic inflammatory response signatures
Show more 93. Anti-inflammatory strategies in acute lung injury

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society